IBIO – ibio, inc. (US:NASDAQ)

News

iBio (NASDAQ:IBIO) was upgraded by analysts at Lifesci Capital to a "strong-buy" rating.
iBio (NASDAQ:IBIO) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
iBio to Participate in the 8th Annual Evercore Healthcare Conference
iBio (NASDAQ:IBIO) was upgraded by analysts at Wall Street Zen from
iBio Reports Q1 Fiscal Year 2026 Financial Results and Provides Corporate Update [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com